CYP2D6

Results: 88



#Item
51January[removed]Volume 2 Issue 1 Pharmacogenetic Testing: How It Can Help Your Patients

January[removed]Volume 2 Issue 1 Pharmacogenetic Testing: How It Can Help Your Patients

Add to Reading List

Source URL: www.shodair.org

Language: English - Date: 2013-12-05 14:21:18
52Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Add to Reading List

Source URL: www.coriell.org

Language: English - Date: 2014-02-06 16:14:40
53Microsoft PowerPoint[removed]Pharmacogenomics- LOURENCO - website

Microsoft PowerPoint[removed]Pharmacogenomics- LOURENCO - website

Add to Reading List

Source URL: www.ich.org

Language: English - Date: 2012-06-22 04:07:47
54Biocatalysis Hydroxylation reactions with P450 enzymes Hydroxylation reactions catalysed using P450 enzymes have a range of applications in drug metabolite production and lead diversification Facilitating the identificat

Biocatalysis Hydroxylation reactions with P450 enzymes Hydroxylation reactions catalysed using P450 enzymes have a range of applications in drug metabolite production and lead diversification Facilitating the identificat

Add to Reading List

Source URL: www.che.caltech.edu

Language: English - Date: 2013-11-25 02:28:47
55©American College of Medical Genetics  original research article Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory

©American College of Medical Genetics original research article Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2012-04-04 15:27:58
56Development of a Pharmacogenetic Predictor “CYP2D6 for Tamoxifen”

Development of a Pharmacogenetic Predictor “CYP2D6 for Tamoxifen”

Add to Reading List

Source URL: ncifrederick.cancer.gov

Language: English - Date: 2013-01-24 13:04:15
57Inferring Impact of Metabolism on Toxicity Outcomes for ToxCast Phase I Chemicals Patra Volarath1, Bruno Bienfait2, Johann Gasteiger2, Keith Houck1, Ann Richard1 1 U.S. EPA, ORD, National Center for Computational Toxicol

Inferring Impact of Metabolism on Toxicity Outcomes for ToxCast Phase I Chemicals Patra Volarath1, Bruno Bienfait2, Johann Gasteiger2, Keith Houck1, Ann Richard1 1 U.S. EPA, ORD, National Center for Computational Toxicol

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2012-05-07 10:17:00
58Incorporating Population Variability into Dosimetry for High-Throughput Toxicity Testing SOT Annual Meeting March 13, 2013 Barbara A. Wetmore

Incorporating Population Variability into Dosimetry for High-Throughput Toxicity Testing SOT Annual Meeting March 13, 2013 Barbara A. Wetmore

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2013-04-10 16:29:10
59Phenotyping Studies in Children: Why, How and Issues to be Addressed J. Steven Leeder, Pharm.D., Ph.D. Clinical Pharmacology and Medical Toxicology Children’s Mercy Hospitals and Clinics Kansas City, MO

Phenotyping Studies in Children: Why, How and Issues to be Addressed J. Steven Leeder, Pharm.D., Ph.D. Clinical Pharmacology and Medical Toxicology Children’s Mercy Hospitals and Clinics Kansas City, MO

Add to Reading List

Source URL: www.fda.gov

Language: English
60ToxCast Assays 01aug2007.xls

ToxCast Assays 01aug2007.xls

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2012-05-07 10:09:55